Neurodevelopmental outcomes of children born to mothers with epilepsy

Article Type
Changed
Tue, 10/30/2018 - 12:17
Display Headline
Neurodevelopmental outcomes of children born to mothers with epilepsy
Article PDF
Author and Disclosure Information

Kimford J. Meador, MD
Department of Neurology, Georgetown University Hospital, Washington, DC

Mary L. Zupanc, MD
Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

Correspondence: Kimford J. Meador, MD, Department of Neurology, Georgetown University Hospital, 1st Floor Bles, 3800 Reservoir Rd., NW, Washington, DC 20007; e-mail: kjm32@georgetown.edu

Dr. Meador receives grants from GlaxoSmithKline, Novartis, Ortho-McNeil, Pfizer, Shire, and UCB Pharma; is a consultant for GlaxoSmithkline, Elan, Lexicor Health Systems, Neuropace, Novartis, Ortho-McNeil, Pfizer, Shire, and UCB Pharma; and has received honoraria from GlaxoSmithKline, Ortho-McNeil, Pfizer, Shire, and UCB Pharma.

Dr. Zupanc is a consultant for and has received honoraria from GlaxoSmithKline, UCB Pharma, Ortho-McNeil, Cyberonics, and Elan.

Publications
Page Number
S38-S41
Author and Disclosure Information

Kimford J. Meador, MD
Department of Neurology, Georgetown University Hospital, Washington, DC

Mary L. Zupanc, MD
Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

Correspondence: Kimford J. Meador, MD, Department of Neurology, Georgetown University Hospital, 1st Floor Bles, 3800 Reservoir Rd., NW, Washington, DC 20007; e-mail: kjm32@georgetown.edu

Dr. Meador receives grants from GlaxoSmithKline, Novartis, Ortho-McNeil, Pfizer, Shire, and UCB Pharma; is a consultant for GlaxoSmithkline, Elan, Lexicor Health Systems, Neuropace, Novartis, Ortho-McNeil, Pfizer, Shire, and UCB Pharma; and has received honoraria from GlaxoSmithKline, Ortho-McNeil, Pfizer, Shire, and UCB Pharma.

Dr. Zupanc is a consultant for and has received honoraria from GlaxoSmithKline, UCB Pharma, Ortho-McNeil, Cyberonics, and Elan.

Author and Disclosure Information

Kimford J. Meador, MD
Department of Neurology, Georgetown University Hospital, Washington, DC

Mary L. Zupanc, MD
Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

Correspondence: Kimford J. Meador, MD, Department of Neurology, Georgetown University Hospital, 1st Floor Bles, 3800 Reservoir Rd., NW, Washington, DC 20007; e-mail: kjm32@georgetown.edu

Dr. Meador receives grants from GlaxoSmithKline, Novartis, Ortho-McNeil, Pfizer, Shire, and UCB Pharma; is a consultant for GlaxoSmithkline, Elan, Lexicor Health Systems, Neuropace, Novartis, Ortho-McNeil, Pfizer, Shire, and UCB Pharma; and has received honoraria from GlaxoSmithKline, Ortho-McNeil, Pfizer, Shire, and UCB Pharma.

Dr. Zupanc is a consultant for and has received honoraria from GlaxoSmithKline, UCB Pharma, Ortho-McNeil, Cyberonics, and Elan.

Article PDF
Article PDF
Page Number
S38-S41
Page Number
S38-S41
Publications
Publications
Article Type
Display Headline
Neurodevelopmental outcomes of children born to mothers with epilepsy
Display Headline
Neurodevelopmental outcomes of children born to mothers with epilepsy
Citation Override
Cleveland Clinic Journal of Medicine 2004 February;71(suppl 2):S38-S41
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media